Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases.
Savara Inc. is a dynamic biopharmaceutical company dedicated to addressing rare respiratory diseases, marking a significant presence in the pharmaceutical manufacturing sector. Savara Inc. is focused on advancing innovative therapies, with its lead program, MOLBREEVI, currently in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). This demonstrates Savara's commitment to providing solutions for unmet medical needs.
Savara Inc. is strategically positioned in the United States, driving advancements in pulmonary medicine. The company's dedication to innovation is evident in its development of therapies like MOLBREEVI, delivered via an investigational eFlow® Nebulizer System. Savara's focus on rare respiratory conditions underscores its role in improving patient outcomes and quality of life. The primary address for Savara Inc. is in the United States.
Savara Inc. is poised for continued growth and success in the biopharmaceutical industry. We invite the manager of Savara Inc. to create a customized and exclusive company showcase and product listing on our platform, further enhancing their visibility and commercial development.
Compare Savara Inc. with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
Savara Inc.Main Company |
PPDView Profile |
Radiopharm Theranost...View Profile |
PhosphorexView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2021 | 2005 |
|
Company Size
|
— | 10,001+ | 2-10 | 11-50 |
|
City
|
Wilmington, NC | Hopkinton, MA | ||
|
Country
|
United States | United States | ||
|
Skills & Keywords
Comparing with main company
|
19 Total Skills
Biopharmaceutical
Respiratory Diseases
Pharmaceutical Manufacturing
Pulmonary Medicine
Drug Delivery
MOLBREEVI
Autoimmune Pulmonary Alveolar Proteinosis
respiratory
aerosol
biopharma
biotech
therapeutics
dpi
rare disease
inhaler
dry-powder
pulmonary
drug delivery
lung
|
17 Total
17 Unique
Unique Skills:
bioanalytical
biopharmaceutical
biostatistics
biotechnology
clinical research
consulting
+11
|
25 Total
25 Unique
Unique Skills:
antibodies
biotechnology
braincancer
breastcancer
breastcancerimaging
cancer
+19
|
19 Total
19 Unique
Unique Skills:
CDMO
controlled release
drug release
formulation of nRNAs & DNAs
gene delivery
Lipids Nano Particles
+13
|
Other organizations in the same industry
This company is also known as